Kestra Medical Technologies, a trailblazer in wearable cardiac technology, has recently announced its intention to go public with a $100 million IPO. The company specializes in a comprehensive Cardiac Recovery System, highlighted by its ASSURE WCD, a next-generation wearable cardioverter defibrillator designed for patients at high risk of sudden cardiac arrest. With a significant adoption rate across numerous U.S. hospitals and a robust sales track record, Kestra is poised to make a significant impact on cardiac health management.The post Wearable Cardiac Device Maker Kestra Medical Technologies Files For A $100 Million IPO appeared first on Ponoko.